ישראל - עברית - Ministry of Health

abbott medical laboratories ltd - niacin 500 mg - film coated tablets - extended release - nicotinic acid - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hyperlipidemia. niacin therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. 1.niaspan is indicated to reduce elevated tc, ldl-c, apo b and tg levels, and to increase hdl-c in patients with primary hyperlipidemia and mixed dyslipidemia. 2.niaspan in combination with simvastatin or lovastatin is indicated for the treatment of primary hyperlipidemia and mixed dyslipidemia when treatment with niaspan, simvastatin, or lovastatin monotherapy is considered inadequate. 3.in patients with a history of myocardial infarction and hyperlipidemia, niacin is indicated to reduce the risk of recurrent nonfatal myocardial infarction. 4.in patients with a history of coronary artery disease (cad) and hyperlipidemia, n

ישראל - עברית - Ministry of Health

sanofi - aventis israel ltd - metronidazole 500 mg - pessary - metronidazole - trichomoniasis.

ישראל - עברית - Ministry of Health

bioavenir ltd - cefuroxime as axetil 500 mg - film coated tablets - cefuroxime - treatment of infections caused by micro-organisms susceptible to cefuroxime.

ישראל - עברית - Ministry of Health

bioavenir ltd - cefuroxime as axetil 500 mg - film coated tablets - cefuroxime - treatment of infections caused by micro-organisms susceptible to cefuroxime.

ישראל - עברית - Ministry of Health

medic trim healthcare ltd - amikacin as sulfate 500 mg / 2 ml - solution for injection - amikacin - treatment of serious nosocomial gram-negative bacillary and in some gram-positive infections in hospitals where resistance to gentamicin and tobarmicin has been found

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - levofloxacin hemihydrate 500 mg - tablets - levofloxacin - in adults with infections of mild to moderate severity levofloxacin teva tablets are indicated for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: - acute sinusitis. - acute exacerbation of chronic bronchitis. - community-acquired pneumonia. - complicated urinary tract infections including pyelonephritis. - skin and soft tissue infections.

ישראל - עברית - Ministry of Health

medison pharma ltd - daptomycin 500 mg/vial - lyophilized powder for injection - daptomycin - cubicin (daptomycin for injection) is indicated for the treatment of complicated skin and skin structure infections caused by susceptible strains of the following gram-positive microorganisms: staphylococcus aureus (including methicillin-resistant strains) streptococcus pyogenes streptococcus agalactiae streptococcus dysgalactiae subsp. equisimilis and enterococcus faecalis (vancomycin-susceptible strains only). combination therapy may be clinically indicated if the documented or presumed pathogens include gram-negative or anaerobic organisms. daptomycin is not indicated for the treatment of pneumonia. appropriate specimens for microbiological examination should be obtained in order to isolate and identify the causative pathogens and to determine their susceptibility to daptomycin. empiric therapy may be initiated while awaiting test results. antimicrobial therapy should be adjusted as needed based upon test results. to reduce the development of drug-resistant bacteria and maintain the effectiveness of cubici

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - valaciclovir hydrochloride (as dihydrate) 500 mg - film coated tablets - valaciclovir - valaciclovir teva is indicated for the treatment of herpes zoster (shingles) in immunocompetent adults . valaciclovir teva accelerates the resolution of pain, it reduces the duration, and the proportion of patients with zoster-associated pain, which includes acute and post-herpetic neuralgia. the efficacy of valaciclovir teva in immunocompromised patients has not been established. - valaciclovir teva is indicated for the treatment of the initial and recurrent genital herpes due to herpes simplex infection. - valaciclovir is indicated for the prevention (suppression) of recurrent herpes simplex infections (herpes genitalis). - prophylaxis of cytomegalovirus infection and disease, following organ transplantation. - for the treatment of cold sores (herpes labialis).

ישראל - עברית - Ministry of Health

roche pharmaceuticals (israel) ltd - capecitabine 500 mg - film coated tablets - capecitabine - adjuvant colon cancer: xeloda is indicated for the adjuvant treatment of patients following surgery of stage iii (dukesע stage c) colon cancer. colorectal cancer: xeloda is indicated for the treatment of patients with advanced or metastatic colorectal cancer advanced gastric cancer: xeloda is indicated for first line treatment of advanced gastric cancer in combination with chemotherapy breast cancer combination therapy: xeloda in combination with docetaxel is indicated for the treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing chemotherapy. breast cancer monotherapy: xeloda is also indicated for the treatment of advanced or metastatic breast cancer after failure of standard therapy including a taxane unless therapy with a taxane is clinically contraindicated.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - mycophenolate mofetil 500 mg - film coated tablets - mycophenolic acid - prophylaxis of rejection in renal allograft recipients, and in patients receiving allogenic cardiac transplants. allogenic hepatic transplant. mefetil should be used concomitantly with cyclosporin and corticosteroids.